首页> 美国卫生研究院文献>AAPS PharmSciTech >Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A
【2h】

Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A

机译:含有维生素A固体脂质纳米颗粒的局部用制剂的开发和评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this research was to investigate novel particulate carrier system such as solid lipid nanoparticles (SLN) for topical application of vitamin A palmitate and to study its beneficial effects on skin. Topical gels enriched with SLN of vitamin A were prepared. The solid lipid nanoparticulate dispersion was prepared using high-pressure homogenization technique and was incorporated into polymeric gels of Carbopol, Pemulen, Lutrol, and Xanthan gum for convenient application. The nanoparticulate dispersion and its gels were evaluated for various parameters such as particle size, in vitro drug release, in vitro penetration, in vivo skin hydration, and skin irritation. The solid lipid nanoparticulate dispersion showed mean particle size of 350 nm. Differential scanning calorimetry studies revealed no drugexcipient incompatibility. In vitro release profile of vitamin A palmitate from nanoparticulate dispersion and its gel showed prolonged drug release up to 24 hours, which could be owing to embedment of drug in the solid lipid core. In vitro penetration studies showed almost 2 times higher drug concentration in the skin with lipid nanoparticle-enriched gel as compared with conventional gel, thus indicating better localization of the drug in the skin. In vivo skin hydration studies in albino rats revealed increase in the thickness of the stratum corneum with improved skin hydration. The developed formulation was nonirritant to the skin with no erythema or edema and had primary irritation index of 0.00. Thus it can be concluded that SLN represents a promising particulate carrier having controlled drug release, improved skin hydration, and potential to localize the drug in the skin with no skin irritation.
机译:这项研究的目的是研究新型颗粒载体系统,例如用于局部应用维生素A棕榈酸酯的固体脂质纳米颗粒(SLN),并研究其对皮肤的有益作用。制备了富含维生素A SLN的局部用凝胶。使用高压均质技术制备固体脂质纳米颗粒分散体,并将其掺入Carbopol,Pemulen,Lutrol和Xanthan胶的聚合物凝胶中,以方便使用。评价纳米颗粒分散体及其凝胶的各种参数,例如粒径,体外药物释放,体外渗透,体内皮肤水合作用和皮肤刺激性。固体脂质纳米颗粒分散体显示出350nm的平均粒度。差示扫描量热法研究显示没有药物赋形剂不相容性。维生素A棕榈酸酯从纳米颗粒分散体及其凝胶的体外释放曲线显示药物释放延长至24小时,这可能是由于药物在固体脂质核心中的嵌入所致。体外渗透研究表明,与传统凝胶相比,富含脂质纳米颗粒的凝胶在皮肤中的药物浓度几乎高出2倍,因此表明药物在皮肤中的定位更好。对白化病大鼠的体内皮肤水合作用研究表明,角质层厚度增加,皮肤水合作用提高。开发的配方对皮肤无刺激性,无红斑或浮肿,主要刺激指数为0.00。因此可以得出结论,SLN代表了一种有前途的颗粒载体,它具有可控的药物释放,改善的皮肤水合作用,并且具有将药物定位在皮肤中而不会刺激皮肤的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号